Integral Health Asset Management, LLC Gossamer Bio, Inc. Transaction History

Integral Health Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $2.16 Million - $4.46 Million	300,000 New	300,000 $3.59 Million
Q4 2020 Feb 16, 2021	SELL	$8.3 - $13.59 $1.66 Million - $2.72 Million	-200,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$11.3 - $14.75 $791,000 - $1.03 Million	-70,000 Reduced 25.93%	200,000 $2.48 Million
Q2 2020 Aug 14, 2020	BUY	$9.52 - $15.98 $2.57 Million - $4.31 Million	270,000 New	270,000 $3.51 Million
Q1 2020 May 15, 2020	SELL	$8.0 - $15.48 $480,000 - $928,800	-60,000 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$14.82 - $26.79 $889,200 - $1.61 Million	60,000 New	60,000 $938,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $93M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.